Nonattendance in a cervical cancer screening program - What happens if women's requirements are met?

Health Care for Women International

Volumn 29, Issue 2, 2008, Pages 183-197

  Oscarsson, Marie G ^a,b   Wijma, Barbro E ^b   Benzein, Eva G ^a  

^a LINNAEUS UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CASE CONTROL STUDY; FEMALE; HEALTH BEHAVIOR; HUMAN; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PREVENTIVE HEALTH SERVICE; PSYCHOLOGICAL ASPECT; RISK FACTOR; STATISTICS; SWEDEN; TREATMENT REFUSAL; UTERINE CERVIX TUMOR; UTILIZATION REVIEW; VAGINA SMEAR; WOMEN'S HEALTH;

ADULT; AGED; CASE-CONTROL STUDIES; DIAGNOSTIC SERVICES; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; RISK FACTORS; SWEDEN; TREATMENT REFUSAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH;

EID: 41149119459     PISSN: 07399332     EISSN: 10964665     Source Type: Journal    
DOI: 10.1080/07399330701738242     Document Type: Article

References (29)

1. Adab, P., Marshall, T., Rouse, A., Randhawa, B., Sangha, H., & Bhangoo, N. (2003). Randomized controlled trial of the effect of evidence based information on women's willingness to participate in cervical cancer screening. Journal of Epidemiology and Community Health, 57(8), 589-593.
2. Austoker, J. (1999). Gaining informed consent for screening is difficult-but many misconceptions need to be undone. British Medical Journal, 3190212), 722-723.
3. Bergstrom, R., Sparen, P., & Adami, H. O. (1999). Trends in cancer of the cervix uteri in Sweden following cytological screening. British Journal of Cancer., 81(1), 159-166.
4. Coleman, D., Day, N., Douglas, G., Farmery, E., Lynge, E., Philip, J., et al. (1993). European guidelines for quality assurance in cervical cancer screening. Europe against cancer programme. European Journal of Cancer, 29A(Suppl. 4), S1-S38.
5. Crombie, I. K., Orbell, S., Johnston, G., Robertson, A. J., & Kenicer, M. (1994). Cervical screening: The optimum visit plan for contacting users and non-users in Scotland. Journal of Epidemiology and Community Health, 48(6), 586-589.
6. Dillman, D. A. (2006). Mail and Internet surveys: The tailored design method (3rd ed.). New York: Wiley.
7. Donovan, J. L., & Blake, D. R. (1992). Patient non-compliance: Deviance or reasoned decision-making? Social Science and Medicine, 34(5), 507-513.
8. Eaker, S., Adami, H. O., Granath, F., Wilander, E., & Sparen, P. (2004). A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiology, Biomarkers and Prevention,, 13(5), 346-354.
9. Eaker, S., Adami, H. O., & Sparen, P. (2001). Attitudes to screening for cervical cancer: A population-based study in Sweden. Cancer Causes and Control,, 12(6), 519-528.
10. Elkind, A. K., Haran, D., Eardley, A., & Spencer, B. (1988). Reasons for non-attendance for computer-managed cervical screening: Pilot interviews. Social Science and Medicine, 27(6), 651-660.
11. Elkind, A. K., Haran, D., Eardley, A., & Spencer, B. (1989). Well you can come in but I'm not having it. The role of the health visitor in computer-managed cervical screening. Health Visitor, 62(1), 20-21.
12. Forbes, C., Jepson, R., & Martin-Hirsch, P. (2002). Interventions targeted at women to encourage the uptake of cervical screening, Cochrane Database of Systematic Reviews (5), CD002834.
13. Foster, P., & Anderson, C. M. (1998). Reaching targets in the national cervical screening programme: Are current practices unethical? Journal of Medical Ethics, 24(5), 151-157.
14. Gustafsson, L., & Adami, H. O. (1990). Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation. British Journal of Cancer, 61(6), 903-908.
15. International Agency or Research on Cancer (IARC), (1986). Screening for squamous cervical cancer: Duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes. British Medical Journal (Clinical Research Ed.), 293(6548), 659-664.
16. Jepson, R. G., Forbes, C. A., Sowden, A. J., & Lewis, R. A. (2001). Increasing informed uptake and non-uptake of screening: Evidence from a systematic review. Health Expectation, 4(2), 116-126.
17. Laverack, G. (2004). Health promotion practice: Power and empowerment. London: Sage.
18. Orbell, S., Crombie, I., Robertson, A., Johnston, G., & Kenicer, M. (1995). Assessing the effectiveness of a screening campaign: Who is missed by 80% cervical screening coverage? Journal of the Royal Society of Medicine, 88(1), 389-394.
19. Oscarsson, M., & Benzein, E. (2002). Women's experiences of pelvic examination: An interview study. Journal of Psychosomatic Obstetrics and Gynaecology, 23(1), 17-25.
20. Oscarsson, M., Benzein, E., & Wijma, B. (In press). Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden. Journal of Psychosomatic Obstetrics and Gynaecology.
21. Oscarsson, M., Wijma, B., & Benzein, E. (In press). "I do not need to.... I do not want to.... I do not give it priority.... " - why women choose not to attend cervical cancer screening. Health Expectations.
22. Ponten, J., Adami, H. O., Bergstrom, R., Dillner, J., Friberg, L. G., & Gustafsson, L. (1995). Strategies for global control of cervical cancer. International Journal of Cancer, 60(1), 1-26.
23. Raffle, A. E. (2001). Information about screening - Is it to achieve high uptake or to ensure informed choice? Health Expectation, 4(2), 92-98.
24. Rissel, C. (1994). Empowerment: The holy grail of health promotion. Health Promotion International, 9(1), 59-41.
25. Sankaranarayanan, R., & Ferlay, J. (2006). Worldwide burden of gynaecological cancer: The size of the problem. Best Practice & Research. Clinical Obstetrics & Gynaecology, 20(2), 207-225.
26. Socialstyrelsen, (1998). Gynekologisk cellprovskontroll: Fòrslag till screeningprogram (Cervical cancer screening: Suggestions for a screening program). Stockholm: Socialstyrelsen.
27. Stenvall, H., Wikstrom, I., & Wilander, E. (2007). High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening. Acta Dermato-Venereologica, 57(3), 243-245.
28. van Ballegooijen, M., van den Akker-van Marle, E., Patnick, J., Lynge, E., Arbyn, M., Anttila, A., et al. (2000). Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. European Journal of Cancer, 36(11), 2177-2188.
29. Wijma, B., & Siwe, K. (2004). Examiner's unique possibilities to catalyze women's empowerment during a pelvic examination. Acta Obstetricia et Gynecologica Scandinavica, 83(12), 1102-1103.